TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Recipharm AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
52,549
|
63,585
|
53,506 |
| Financial expenses |
89,900
|
588,500
|
308,075 |
| Earnings before taxes |
462,875
|
-793,989
|
-1,895 |
| EBITDA |
-24,785
|
-27,622
|
-15,852 |
| Total assets |
1,765,898
|
2,068,057
|
2,651,743 |
| Current assets |
677,875
|
1,173,126
|
357,185 |
| Current liabilities |
213,635
|
396,490
|
190,008 |
| Equity capital |
681,809
|
825,812
|
1,616,087 |
| - share capital |
4,402
|
4,556
|
4,543 |
| Employees (average) |
44
|
60
|
67 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.6%
|
39.9%
|
60.9% |
| Turnover per employee |
1,194
|
1,060
|
799 |
| Profit as a percentage of turnover |
880.8%
|
-1248.7%
|
-3.5% |
| Return on assets (ROA) |
31.3%
|
-9.9%
|
11.5% |
| Current ratio |
317.3%
|
295.9%
|
188.0% |
| Return on equity (ROE) |
67.9%
|
-96.1%
|
-0.1% |
| Change turnover |
-8,875
|
9,923
|
31,232 |
| Change turnover % |
-14%
|
18%
|
140% |
| Chg. No. of employees |
-16
|
-7
|
3 |
| Chg. No. of employees % |
-27%
|
-10%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.